Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progression

Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig
doi: https://doi.org/10.1101/2021.02.23.21251891

Article Information

doi 
https://doi.org/10.1101/2021.02.23.21251891
History 
  • February 24, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Bastian Fischera,*,
  2. Christopher Lindenkampa,
  3. Christoph Lichtenberg,
  4. Ingvild Birschmann,
  5. Cornelius Knabbeb and
  6. Doris Hendigb
  1. Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstrasse 11, 32545 Bad Oeynhausen, Germany
  1. ↵*E-mail: bfischer{at}hdz-nrw.de

  1. ↵a These authors contributed equally to this work.

  2. ↵b These authors contributed equally to this work.

Back to top
Posted February 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progression
Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig
medRxiv 2021.02.23.21251891; doi: https://doi.org/10.1101/2021.02.23.21251891
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area